Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

Tracking in situ checkpoint inhibitor-bound target T cells in patients with checkpoint-induced colitis

Gupta T. et al, (2024), Cancer Cell, 42, 797 - 814.e15

Interferon-Gamma–Producing CD8+ Tissue Resident Memory T Cells Are a Targetable Hallmark of Immune Checkpoint Inhibitor–Colitis

Sasson SC. et al, (2021), Gastroenterology, 161, 1229 - 1244.e9

Spatiotemporal analysis of human intestinal development at single-cell resolution

Fawkner-Corbett D. et al, (2021), Cell, 184, 810 - 826.e23

Single-cell atlas of colonic CD8+ T cells in ulcerative colitis

Corridoni D. et al, (2020), Nature Medicine, 26, 1480 - 1490

Immune checkpoint inhibitor-related colitis assessment and prognosis: can IBD scoring point the way?

Cheung VTF. et al, (2020), British Journal of Cancer, 123, 207 - 215

Aortic valve area using computed tomography‐derived correction factor to improve the validity of left ventricular outflow tract measurements

Alskaf E. et al, (2020), Echocardiography, 37, 196 - 206

Immune checkpoint inhibitor-related colitis assessment and prognosis: can inflammatory bowel disease scoring point the way?

Cheung VTF. et al, (2020), JOURNAL OF CROHNS & COLITIS, 14, S286 - S288

RODE: Learning Roles to Decompose Multi-Agent Tasks.

Wang T. et al, (2020), CoRR, abs/2010.01523

Tissue-based activation of mucosal-associated invariant T (MAIT) cells in combination ipilimumab and nivolumab checkpoint inhibitor (CI) colitis

Sasson SC. et al, (2019), ANNALS OF ONCOLOGY, 30, 530 - 530

IMMUNOTHERAPY-RELATED GASTRITIS IN A TERTIARY ONCOLOGY CENTRE

Cheung V. et al, (2019), GUT, 68, A147 - A148

Immunotherapy-related hepatitis: real-world experience from a tertiary centre

CHEUNG VINCENT. et al, (2019), Frontline Gastroenterology

Immunotherapy-related hepatitis: Real-world experience from a tertiary centre

Cheung V. et al, (2019), Frontline Gastroenterology

Real-world data: the incidence, diagnosis, and management outcomes of patients with immunotherapy-related colitis in two tertiary centres

Cheung V. et al, (2019), JOURNAL OF CROHNS & COLITIS, 13, S137 - S138

Include forthcoming?